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Progesterone, estradiol, arachidonic acid, oxytocin,
forskolin and cAMP influence on aquaporin 1 and
5 expression in porcine uterine explants during
the mid-luteal phase of the estrous cycle and
luteolysis: an in vitro study
Agnieszka Skowronska1*, Patrycja Młotkowska2, Bartosz Wojciechowicz2, Stanisław Okrasa2, Soren Nielsen3
and Mariusz T Skowronski2,4
Abstract
Background: The cell membrane water channel protein, aquaporins (AQPs), regulate cellular water transport and
cell volume and play a key role in water homeostasis. Recently, AQPs are considered as important players in the
field of reproduction. In previous studies, we have established the presence of AQP1 and 5 in porcine uterus. Their
expression at protein level altered in distinct tissues of the female reproductive system depending on the phase of
the estrous cycle. However, the regulation of aquaporin genes and proteins expression has not been examined in
porcine uterine tissue. Therefore, we have designed an in vitro experiment to explain whether steroid hormones,
progesterone (P4) and estradiol (E2), and other factors: oxytocine (OT), arachidonic acid (AA; substrate for prostaglandins
synthesis) as well as forskolin (FSK; adenylate cyclase activator) and cAMP (second messenger, cyclic adenosine
monophosphate) may impact AQPs expression.
Methods: Uterine tissues were collected on Days 10–12 and 14–16 of the estrous cycle representing the mid-luteal
phase and luteolysis. Real-time PCR and Western blot analysis were performed to examine the expression of porcine
AQP1 and AQP5. Their expression in the uterine explants was also evaluated by immunohistochemistry.
Results: The results indicated that uterine expression of AQP1 and AQP5 potentially remains under control of steroid
hormones and AA-derived compounds (e.g. prostaglandins). P4, E2, AA, FSK and cAMP cause translocation of AQP5 from
apical to the basolateral plasma membrane of the epithelial cells, which might affect the transcellular water movement
(through epithelial cells) between uterine lumen and blood vessels. The AC/cAMP pathway is involved in the intracellular
signals transduction connected with the regulation of AQPs expression in the pig uterus.
Conclusions: This study documented specific patterns of AQP1 and AQP5 expression in response to P4, E2, AA, FSK and
cAMP, thereby providing new indirect evidence of their role in maintaining the local fluid balance within the uterus
during the mid-luteal phase of the estrous cycle and luteolysis in pigs.
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Background
Since the discovery of aquaporins (AQPs), water channel
proteins, a high rate of transcellular water flow is believed
to be mediated by these specialized protein transporters.
Recently, AQPs have become considered to be important
players in the field of reproduction, see reviews [1, 2]. Sev-
eral AQP isoforms are expressed in the female reproduct-
ive tissues: ovary, uterus, placenta, amnion and chorion
cytotrophoblasts [3–10]. Their specific expression pattern
suggests that they participate in water movement between
the intraluminal, interstitial and capillary compartments.
Further studies have demonstrated that AQPs are also
involved in endometrial development, cell migration and
invasion [11]. Aquaporin 1 and 5 are water selective and
belong to the classical AQP family [12]. AQP1 is a 28-kDa
water channel protein expressed in the endothelial and
epithelial cells of many tissues, increasing water perme-
ability of the cell membrane. AQP5 has mainly been local-
ized in apical plasma membranes of various secretory
glands [13]. The important role of AQP5 in water homeo-
stasis is evidenced by AQP5-null mice which have reduced
saliva secretion [14].
The expression of AQPs in uterine tissue was first
described by Li et al. [15], who confirmed the presence
of AQP1 transcript in the human uterus. Afterwards, Li
et al. [16] demonstrated that AQP1 mRNA expression in
the rat uterus is up-regulated by estradiol. Accumulating
evidence indicated that ovarian steroids can affect the
expression of several AQPs in the reproductive system,
including the uterus [17, 18]. The presence of AQP1, 2
and 5 has also been studied throughout the estrous cycle
in bitches [19]. Very recently, Klein et al. [20] showed
uterine mRNA expression of 12 different AQPs subtypes
in endometrium of cyclic and pregnant mares. More-
over, it was demonstrated that cAMP is involved in
up-regulation of some AQPs in a variety of cell types
[9,21–24]. The presence of AQP1 in human endometrial
blood vessels indicates its involvement in the regulation of
edema, and in the regulation of angiogenesis [25] as well
as pathological processes related to ovulatory uterine
bleeding in women [26].
Studies on pigs suggest a functional collaboration among
diverse AQPs within the uterus during different phases of
the estrous cycle and early pregnancy [27]. It has been
shown that AQP5 is localized in myometrial and epithelial
cells of the uterus, but AQP1 in uterine endometrial and
myometrial blood vessels [7, 27]. Their expression at a
protein level was also altered in distinct tissues depending
on the phase of the estrous cycle and the stages of early
pregnancy. However, the regulation of aquaporin genes
and protein expression has not been examined in porcine
uterine tissue. Therefore, we have designed an in vitro
experiment to explain whether steroid hormones, proges-
terone (P4) and estradiol (E2), and other factors: oxytocine
(OT), arachidonic acid (AA; substrate for prostaglandins
synthesis) as well as forskolin (FSK; adenylate cyclase
activator) and cAMP (cyclic adenosine monophosphate;
second messenger) may have impact on the AQPs expres-
sion. Consequently, the primary aim of this study was;
(i) to examine the changes in AQP1 and AQP5 at mRNA
and protein levels in porcine uterine explants in the pres-
ence of P4, E2, OT, AA, FSK and cAMP; and then (ii) to
describe the effect of tissue exposition duration to the
experimental factors on the AQPs expression; (iii) to com-
pare their expression in the uterine explants, representing
the mild-luteal phase of the estrous cycle and luteolysis;
(iv) to determine the localization of AQP1 and 5 in uterine
explants after the treatments. This study provided add-
itional information concerning factors potentially respon-
sible for water homeostasis in porcine uterus during the
mid-luteal phase and luteolysis in the pig.
Methods
Experimental animals and collection of uterine tissue
All experiments were performed in accordance with
Animal Ethics Committee, University of Warmia and
Mazury in Olsztyn, Poland (AEC approval No. 66/2010/
DTN). Tissue samples were recovered from mature
cross-bred gilts (Large White × Polish Landrace) on Days
10–12 (n = 5 per group) during the mid-luteal phase and
on Days 14–16 (n = 5 per group) of the estrous cycle
(the stage of luteolysis). Gilts were observed daily for
estrous behavior, and they were used in the study during
their third consecutive normal estrous cycle. The ani-
mals were slaughtered at a local abattoir on Days10-12,
corresponding to the period with increased plasma pro-
gesterone (P4) concentration, or Days 14–16, the period
of decreasing plasma P4 concentration and luteal regres-
sion, of the estrous cycle. Additionally, stage of the cycle
was verified by utero-ovarian morphology [28]. Uteri
were placed immediately in ice-cold phosphate-buffered
saline (PBS) supplemented with 100 IU/ml penicillin (Polfa,
Poland) and 100 μg/ml streptomycin (Polfa, Poland) and
transported to the laboratory on ice within 1 to 1.5 h for
in vitro tissue culture.
Preparation and incubation of uterine slices
Sections of the middle part of uterine horn collected
from pigs were opened longitudinally on the mesome-
trial surface. Uteri were washed three times in sterile
PBS then carefully cut into small pieces (400 mg weight)
and then washed three times in medium M199 (Sigma,
USA). Individual uterine slices were placed in culture
vials containing 2 ml Medium 199 supplemented with
0.1% BSA (Sigma), 20 μg nystatin (Sigma) and 20 μg
gentamicin (Krka, Novo Mesto, Slovenia) and then pre-
incubated in vitro under atmosphere of 95% O2 and 5%
CO2 at 37°C for 18 h. After preincubation, the culture
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medium was replaced with fresh medium, and the ex-
plants were treated with vehicle (control) or P4 (10
−5 M;
Sigma), E2 (10
−9 M; Sigma), OT (10−7 M; Sigma), AA
(10−5 M; Sigma), FSK (10 μg/mL; Sigma) and cpt-cAMP
analog (200 μM; Sigma) and incubated for an additional
3 or 24 h. All treatments were performed in triplicates.
Furthermore, uterine tissue explants were snap-frozen in
liquid nitrogen (for RNA and protein extraction) and
stored at −80°C until further use.
Total RNA isolation, cDNA synthesis and quantitative
real-time polymerase chain reaction analysis
Total RNA was extracted, using the total RNA Prep Plus
kit (A&A Biotechnology, Gdansk Poland) according to the
manufacturer`s protocol, from uterine explants collected
after in vitro culture. Total RNA quality and quantity
were determined with spectrophotometry (NanoDrop
ND-1000, Thermo Scientific, Wilmington, DE, USA).
Total RNA samples were transcribed to cDNA using an
Enhanced Avian HS RT-PCR Kit it (Sigma) and a mix
of dNTPs and random hexamers as primers. Real-Time
PCR was performed in duplicate for each sample using
a 7300 Real-Time PCR system and SYBR®Green PCR
Master Mix (Life Technologies, Grand Island, NY,
USA). Real-Time PCR reaction included 12.5 μl SYBR
Green PCR master mix, 1 μM forward and reverse
primers each and reverse transcribed cDNA (3.5 μl of
diluted RT product) supplemented with water to a vol-
ume of 25 μl. The conditions of the thermal cycling for
each gene were: initial denaturation for 10 min at 95°C,
denaturation for 15 sec at 95°C, primer annealing for
1 min at 60°C. Specific primers for AQP1 and AQP5
(Table 1) were designed with the Primer Express 3.0
software (Life Technologies) and their specificities were
confirmed by comparison of their sequences with the
sequence of AQP1 and AQP5 deposited in a database
and calculation of the statistical significance of the
match was performed using the Basic Local Alignment
Search Tool (BLAST). For the specificity control, non-
template controls and dissociation curve analysis of the
amplified products were used for each amplification.
The specificity of amplifications was further validated
with electrophoresis of the putative amplicons in a 2%
agarose gel and, after extraction from gel, automated
sequencing using 3730xl DNA Analyzer (Life Technolo-
gies). Levels of gene expression were calculated using
the ΔΔ Ct method and normalized using the geomet-
rical means of reference genes expression levels, glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) and
18S rRNA.
SDS-PAGE and Western blot
The tissues were placed in ice-cold dissection buffer
(0.3 M sucrose, 25 mM imidazol, 1 mM EDTA in ddH2O,
pH 7.2) containing 8.4 μM leupeptin and 0.4 mM pefabloc
[29]. The tissue samples were homogenized using an ultra
Turrax T8 homogeniser (IKA Labortechnik, Staufen,
Germany) and centrifuged at 4,000 × g for 15 min at 4°C.
The supernatant was diluted in SDS buffer contained a
final concentration of 62 mM Tris (hydroxymethyl)-ami-
nomethane, 0.1 M sodium dodecyl sulphate (SDS), 8.7%
glycerol, 0.09 mM bromophenol blue and 0.04 M dithio-
threitol (DTT), pH 6.8. The protein samples were heated
for 5 min at 90°C and stored in refrigerator for further
analysis. Total protein amounts were determined with
spectrophotometry (NanoDrop ND-1000, Thermo Scien-
tific, Wilmington, DE, USA). The samples warmed up to
37°C were loaded into 12.5% polyacrylamide gels and pro-
teins were separated by electrophoresis. The proteins of
studied gels were then electro-transferred onto nitrocellu-
lose membranes (Hybond ECL RPN3032D, Amersham
Pharmacia Biotech, Little Chalfont, UK) for 1 h at 100 V.
The membranes were blocked with 5% milk in PBS-T
(80 mM Na2HPO4, 20 mM NaH2PO4, 100 mM NaCl,
pH 7.5 and 0.1% vol/vol Tween 20) for 1 h. After washing,
the membranes were incubated overnight at 5°C with
anti-AQPs or β-actin antibodies. Thereafter, the mem-
branes were washed and incubated with horseradish
peroxidase-conjugated goat anti-rabbit IgG secondary
antibody (P448, diluted 1:3,000, Dako A/S, Glostrup,
Denmark) in PBS-T for 1 h. After washing with PBS-T,
the sites of antibody-antigen reaction were visualized with
an enhanced chemiluminescence (ECL) system (Amer-
sham Pharmacia Biotech, Little Chalfont, UK) and expos-
ure to photographic film (Hyperfilm ECL, RPN3103K,
Amersham Pharmacia Biotech, Little Chalfont, UK). The
results of Western blotting were quantified by densitomet-
ric scanning of immunoblots with GelScan for Windows
ver. 1.45 software (Kucharczyk, Poland). Data were
expressed as a ratio of AQP proteins relative to actin
protein in OD units.
Immunohistochemistry
Tissues were fixed by immersion in 4% paraformaldehyde
for 24 hr. For preparation of paraffin-embedded tissue
Table 1 Primer pairs used in the study
PCR product Sequence
AQP1 Forward: 5′-CCAGCGAGTTCAAGAAGAAG-3′
Reverse: 5′-GCGACACCTTCACGTTATC-3′
AQP5 Forward: 5′-CTATGAGTCCGAGGAGGATT-3′
Reverse: 5′-GCTTCGCTGTCATCTGTT-3′
18SrRNA Forward: 5′-GGCTACCACATCCAAGGAAG-3′
Reverse: 5′-TCCAATGGATCCTCGCGGAA-3′
GADPH Forward: 5′-GACCTCCACTACATGGTCTA-3′
Reverse: 5′-AAGATGGTGATGGCCTTTC-3′
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sections (4 μm thickness), the tissues were dehydrated
in ethanol followed by xylene and finally embedded in
paraffin [27]. The staining was carried out using indir-
ect immunoperoxidase. The sections were dewaxed and
rehydrated. For immunoperoxidase labeling, endogen-
ous peroxidase was blocked by 0.5% H2O2 in absolute
methanol for 10 min at room temperature. To reveal
antigens, the sections were submerged in 1 mM Tris
solution (pH 9.0) supplemented with 0.5 mM EGTA
and heated in a microwave oven. After the treatment,
the sections were left for 30 min in the buffer for cooling.
Nonspecific binding of IgG was eliminated by incubating
the sections in 50 mM NH4Cl for 30 min, followed by
blocking in PBS supplemented with 1%BSA, 0.05%
saponin and 0.2% gelatin. The sections were incubated
overnight at 4°C with primary antibodies diluted in PBS
supplemented with 0.1% BSA and 0.3% Triton X-100. The
sections were rinsed with PBS supplemented with 0.1%
BSA, 0.05% saponin and 0.2% gelatin, and then incubated
with horseradish peroxidase-conjugated secondary anti-
body (Dako A/S, Glostrup, Denmark). Labeling was visu-
alized by 0.05% 3,3 diaminobenzidine tetrahydrochloride
(DAB). The microscopy was carried out using an Olympus
light microscope (BX51, Japan).
Primary antibodies
Antibodies to AQP1 and AQP5, used in Western blot
analysis and immunocytochemistry, were previously char-
acterized, respectively by Terris et al. [30] and Nielsen
et al. [13]. All polyclonal antibodies were affinity-purified
(SulfoLink Kit, Pierce, Rockford, IL). Moreover, the anti-β-
actin antibody was used (cat. no. A2066; Sigma-Aldrich,
St Louis, MO). In our previous study, we demonstrated
that anti-AQP1 and anti-AQP5 antibodies preincubated
with the immunizing peptide prevented labeling in the
pig uterus [7]. In addition, immunoglobulins from non-
immunized rabbit were used as a negative control.
Statistical analysis
All numerical data were analyzed by one-way ANOVA
and least significant difference (LSD) post hoc test and
reported as the means ± S.E.M. from five separate exper-
iments (pigs), each performed in duplicates. Statistical
analyses were performed using the Statistica program
(StatSoft Inc., Tulsa, USA). Values for p < 0.05 were con-
sidered statistically significant.
Results
AQP1 mRNA expression in porcine uterine explants
The control abundance of AQP1 transcript harvested in
the uterine tissue from mid-luteal phase (Days 10–12)
was about 4-fold and 2-fold higher (p < 0.05) than on
Days 14–16 (luteolysis) during 3-h and 24-h incubation,
respectively (Figure 1A and B). In porcine uterine
explants from Days 10–12 (the mid-luteal phase) of
the estrous cycle, AQP1 mRNA expression significantly
(p < 0.05) decreased after 3-h treatment with E2 and AA,
in comparison to the respective controls. In turn, longer
treatment (24 h) with FSK significantly (p < 0.05) in-
creased AQP1 mRNA expression, but with P4, oxytocin
and AA it decreased.
Aquaporin 1 gene expression in porcine uterine tis-
sue explants from Days 14–16 (luteolysis), significantly
(p < 0.05) increased after both 3- and 24-h treatment with
E2 (Figure 1B). In contrast, AQP1 mRNA expression
decreased after 3-h treatments with P4 and OT (p < 0.05).
Arachidonic acid, FSK and cAMP did not affect AQP1
mRNA expression during shorter incubation. In turn, an
increase in AQP1 mRNA expression was seen after 24-h
treatment with FSK and cAMP (p < 0.05). A particularly
strong increase (~7-fold) in AQP1 mRNA expression was
noted after 24-h treatment with FSK.
AQP5 mRNA expression in uterine explants
Quantitative expression of AQP5 mRNA in the uterine
explants on Days 10–12 and 14–16 of the estrous cycle
is presented on Figure 2A and B, respectively. The con-
tent of AQP5 transcript in uterine explants following
control incubation was about 2.5 fold lower after 3-h
incubation (p < 0.05) on Days 10–12 of the estrous cycle
in comparison to Days 14–16. Such a difference was not
observed in the case of longer incubation (24 h). During
the mid-luteal phase of the cycle, markedly lower amounts
of AQP5 transcript were noted after treatments with P4,
E2, oxytocin, AA, FSK and cAMP for 3 h as compared to
control value (p < 0.05) and remained lower after 24 hours
(p < 0.05) except for treatment with cAMP.
Treatment with E2 for 3 h of the uterine explants
representing luteolysis (Days 14–16) of the estrous cycle
significantly increased (p < 0.05) AQP5 mRNA expression
(p < 0.05) but OT and FSK treatments significantly de-
creased it. Incubation with P4, E2, OTand AA did not result
in any detectable change in porcine uterine explants AQP5
gene expression after 24-hours incubation. Treatment with
cAMP for 24 h significantly decreased AQP5 gene expres-
sion. Conversely, incubation with FSK after 24 h, signifi-
cantly increased AQP5 gene expression.
Protein content of AQP1 in uterine explants
The effects of P4, E2, oxytocin, AA, FSK and cAMP on
AQP1 protein expression in uterine tissue explants
harvested during the mid-luteal phase (Days 10–12) and
luteolysis (Days 14–16) are shown in Figure 3A and B.
The protein expression of AQP1 in porcine uterine
explants increased (p < 0.05) after treatment with P4 after
3- and 24-h incubation. Estradiol treatment for 3 h did
not significantly affect AQP1 protein expression in the
tissue from mid-luteal phase, however, after longer
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incubation (24 h) E2 stimulated its expression (p < 0.05).
AQP1 protein expression significantly increased after 3-
h treatment with FSK and cAMP. In turn, treatment
with OT and AA did not influence AQP1 expression.
During luteolysis, the content of AQP1 was increased
(from 2.5- to 3-fold; p < 0.05) by P4, E2, AA, FSK and
cAMP after 3-h incubation (Figure 3A). After 24-h incu-
bation, only P4 and E2 significantly stimulated AQP1
expression (p < 0.05), similar to the levels noted after 3-h
incubation (Figure 3A). It is noteworthy that the re-
sponses of AQP1 to E2, AA and forskolin, after short
incubation, appeared to be higher on Days 14–16 than
on Days 10–12 of the estrous cycle.
Protein content of AQP5 in uterine explants
AQP5 expression evaluated by Western blot analysis of
in porcine uterus explants from the mid-luteal phase
and the luteolysis is shown in Figure 4A and B. Bands of
AQP5 protein product of the expected size (28 kDa)
were clearly detected in both stages of the cycle. During
the mid-luteal phase, uterine AQP5 protein expression
significantly (p < 0.05) increased after 3-h and 24-h of
treatment with P4, E2, FSK and cAMP. During luteolysis,
a high increase (~3.0-fold) in AQP5 protein expression
in the tissue was observed in response to P4, E2, FSK and
cAMP after both 3-h and 24-h incubations (p < 0.05).
AQP5 protein content in the uterine tissue was only ele-
vated (~2.5-fold) by 3-h treatment with AA (p < 0.05). In
turn, treatment with OT did not influence AQP5 expres-
sion in the studied tissue. It is noteworthy that AQP5
protein response to some of the studied factors appeared
to be higher on Days 14–16 than on Days 10–12 of the
estrous cycle. In particular, during the luteolysis a higher
AQP5 protein expression was observed after 3-h treat-
ment with P4, E2, FSK and cAMP and remained elevated
for 24 hours in comparison to the mid-luteal phase.
Immunohistochemical localization of AQP1 and AQP5 in
uterine tissue explants
In the tissue sections of the pig uterine explants repre-
senting the mid-luteal phase and luteolysis, immunoper-
oxidase labeling for AQP1 was associated with uterine
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Figure 1 AQP1 mRNA expression in porcine uterine explants. The expression of AQP1 mRNA in the pig uterine tissue harvested on (A)
Days 10–12 (n = 5) and (B) Days 14–16 (n = 5) of the estrous cycle after treatment with progesterone (P4; 10
−5 M), estradiol (E2; 10
−9 M), oxytocin
(OT; 10−7 M), arachidonic acid (AA; 10−5 M), forskolin (FSK; 10 μg/mL) and cyclic-AMP (cAMP; 200 μM) for 3 and 24 h. The data are presented as
the mean values ± SEM of AQP1 expression in relation to expression of GAPDH and 18 sRNA. Different letters (a,b,c,d) indicate significant differences
(p < 0.05) between each treatment and respective control for 3- (a,b) or 24-h (c,d) incubations.
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Figure 2 AQP5 mRNA expression in porcine uterine explants. The expression of AQP5 mRNA in the pig uterine tissue harvested on (A)
Days 10–12 (n = 5) and (B) Days 14–16 (n = 5) of the estrous cycle after treatment with progesterone (P4; 10
−5 M), estradiol (E2; 10
−9 M), oxytocin
(OT; 10−7 M), arachidonic acid (AA; 10−5 M), forskolin (FSK; 10 μg/mL) and cyclic-AMP (cAMP; 200 μM) for 3 and 24 h. The data are presented
as the mean values ± SEM of AQP5 expression in relation to expression of GAPDH and 18 sRNA. Different letters (a,b,c,d) indicate significant
differences (p < 0.05) between each treatment and respective control for 3- (a,b) or 24-h (c,d) incubations.
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explants from (A) Days 10–12 (n = 5) and (B) Days 14–16 (n = 5) of the estrous cycle (each lane represents a sample from 1 pig), after treatment with
progesterone (P4; 10
−5 M), estradiol (E2; 10
−9 M), oxytocin (OT; 10−7 M), arachidonic acid (AA; 10−5 M), forskolin (FSK; 10 μg/mL), and cyclic-AMP (cAMP;
200 μM. Densitometric analysis of the immunoblots was performed and different small letters (a, b,c,d) indicate significant differences (p < 0.05)
between each treatment and respective control for 3- (a,b) or 24-h (c,d) incubations. Different large letters (A, B, C, D) indicate significant differences
between the same treatments for 3- (A,B) or 24-h (C,D) incubations for different periods (Days 10–12 and 14–16) of the estrous cycle (p < 0.05).
dA
C                  P4                 E2                OT               AA              FSK            cAMP
bB bB
bB
bBbB
aA aAcC
dD
dD
cC cC
- 3 h
- 24 h
0
1
2
3
4
5
D
en
si
ty
 (A
rb
it
ar
y 
un
it
s)
dD dD
0
1
2
3
4
5
D
en
si
ty
 (A
rb
it
ar
y 
un
it
s)
bA
aA
bA
bA
aA
aA
cC
dC dC
cC
cC
- 3 h
- 24 h
dC dC
B
28kDa
28kDa
C                  P4                 E2                OT               AA              FSK            cAMP
A
Figure 4 Protein content of AQP5 in uterine explants. Semi-quantitative Western blot analysis of AQP5 in homogenates of the pig uterine
explants from (A) Days 10–12 (n = 5) and (B) Days 14–16 (n = 5) of the estrous cycle (each lane represents a sample from 1 pig), after treatment
with progesterone (P4; 10
−5 M), estradiol (E2; 10
−9 M), oxytocin (OT; 10−7 M), arachidonic acid (AA; 10−5 M), forskolin (FSK; 10 μg/mL) and cyclic-AMP
(cAMP; 200 μM). Different small letters (a, b, c, d) indicate significant differences (p < 0.05) between each treatment and respective control for 3- (a,b)
or 24-h (c,d) incubations. Different large letters (A, B, C, D) indicate significant differences between the same treatments for 3- (A,B) or 24-h (C,D)
incubations for different periods (Days 10–12 and 14–16) of the estrous cycle (p < 0.05).
Skowronska et al. Reproductive Biology and Endocrinology  (2015) 13:7 Page 6 of 11
endothelial cells (Figure 5A and B). Both apical and basal
plasma membranes exhibited stable AQP1 labeling
-without intracellular changes in localization - after 3-h
and 24-h incubation with all examined factors (Figure 5A
and B). However, expression of AQP1 increased after 3-
and 24-h tissue exposition to P4 and E2 on Days 10–12
and 14–16 as well as after 3-h incubation with FSK and
cAMP on Days 10–12, and AA, FSK and cAMP on Days
14–16 of the estrous cycle. As a positive control, AQP1
labeling was seen in the apical and basolateral plasma
membrane in the proximal tubule cells of the pig kidney
(Figure 5Y).
In turn, in sections of the explants treated with exam-
ined factors, immunoperoxidase staining for AQP5 was
associated with uterine epithelial (Figure 5C) and smooth
muscle cells (Figure 5U and W). Moreover, AQP5 labeling
in the uterine epithelial cells was more intensive in the ap-
ical plasma membrane after 3- and 24-h treatment with
OT, AA on Days 10–12 and OT as well as 24-h treatment
with AA on Days 14–16 than those observed in respective
controls. Following 3- and 24-h treatments of the tissue
with P4, E2, FSK and cAMP on Days 10–12 and 14–16 of
the estrous cycle, prominent AQP5 labeling was seen in
both the apical and basolateral plasma membranes of the
epithelial cells (Figure 5D-S). A similar pattern of AQP5
labeling was seen after 3-h treatment with AA on Days
14–16 of the estrous cycle (Figure 5T). In the smooth
muscle cells, in contrast to the epithelial cells, changes in
AQP5 localization within the cell membranes were not
observed in response to applied treatments (Figure 5U-
W). As a positive control, AQP5 antibody noticeably
stained (Figure 5Z) the apical plasma membrane of the
type I pulmonary epithelial cells of the pig.
Discussion
In the present study, we have demonstrated that two iso-
forms of AQPs (1 and 5) mRNAs are expressed in the
porcine uterine explants in both studied periods. In our
previous study, performed with the use of immunohisto-
chemistry and Western blot, AQP1 and 5 were clearly
detected in untreated uterine tissue on Days 10–12 and
14–16 of the estrous cycle. In cyclic gilts, endometrial
and myometrial expression of AQP1 did not change sig-
nificantly, in turn endometrial AQP5 protein expression
was significantly higher on Days 14–16 than on Days
10–12 of the cycle [7]. In the present study, we aimed to
further investigate, using an in vitro system, whether
these AQPs are regulated by steroid hormones, cAMP,
forskolin, arachidonic acid or oxytocin in porcine uterine
tissue at mRNA and protein levels.
In the present study, steroid hormones (P4 and E2) dif-
ferentially influenced the expression of AQP1 and 5 in
porcine uterine tissue under in vitro conditions. AQP1
gene expression was down-regulated by E2 treatment for
3-h during the mid-luteal phase. Furthermore, P4 inhib-
ited AQP1 mRNA gene expression during luteolysis,
after short incubation (3 h). Steroid hormones (P4 and
E2) increased AQP1 protein expression during both
studied stages of the cycle and incubations. Moreover, E2
more effectively stimulated AQP1 protein expression on
Days 14–16 than on Days 10–12 of the cycle. In turn,
AQP5 gene expression was also down-regulated after
treatments with E2 and P4 (3 h and 24 h) during the
mid-luteal phase, but up-regulated by E2 during luteoly-
sis (3 h). As in the case of AQP1, longer incubation with
steroids down-regulated AQP5 mRNA expression during
the mid-luteal phase. Interestingly, the basic (control)
level of AQP1 transcript was higher (after 3- and 24-h
incubations) in the mid-luteal phase (2.07 ± 0.61 and
1.03 ± 0.09, respectively) than during luteolysis, but in
the case of AQP5 (after 3-h incubation) the relationship
was inversed (1.59 ± 0.35 and 4.48 ± 0.71, respectively).
At the protein level, the changes of AQP1 and 5 expres-
sion in response to E2 and P4, were not in full agreement
with those noted for mRNAs.
Our findings concerning the E2 effect on AQP expres-
sion are comparable to those reported by Li et al. [16]
and Kobayashi et al. [31], who studied this steroid action
on the uterine expression of AQP1 in rat and AQP5 in
mouse, respectively. In addition, Kobayashi et al. [31]
revealed the presence of functional estrogen response
element in AQP5 promoter regions which suggests the
possibility of direct action of estrogens on AQP5 expres-
sion. Richard et al. [5] found increased AQP1 mRNA
expression in mice myometrium in response to estrogen,
but AQP5 expression was induced by estrogen only in
progesterone-primed uteri. In several studies, the role of
P4 alone or in combination with estrogens in controlling
AQP expression in uterus has been confirmed. Lindsay
and Murphy [6] reported increased expression of AQP5
in uterine epithelial cells by progesterone alone and in
combination with estrogen. The same authors [18] also
noted progesterone-dependent expression of AQP5 and
AQP1 in the rat uterus; AQP5 in glandular epithelium
and AQP1 in the inner circular layer of myometrium.
Aralla et al. [19] demonstrated coincidently elevated
expression of AQP5 in the apical plasma membrane of
uterine epithelial cells with increased concentrations of
P4 in plasma. Furthermore, in the mouse uterus exogen-
ous estrogen strongly up-regulated the expression of
AQP2, without any effect on AQP5 [17]. Very recently,
the presence of mRNA for all AQPs (AQP0 to 12) has
been shown in equine endometrium, while the Western
blot analysis confirmed protein expression of AQP0, 2
and 5 [20]. To the contrary, progesterone treatment of
anoestrus mares did not enhance the expression of
AQPs, indicating that factors other than progesterone or
some factors in addition to progesterone are required for
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the up-regulation of certain AQP subtypes. The above
observations are not entirely consistent, the discrepancies
seem to result from different animal models and/or
experimental protocols applied in the study. For example,
Jablonski et al. [17] used ovariectomized and hormonally
treated mice, but in the present study porcine uterine
explants were used. In turn, the lack of a full relation-
ship – observed in the present study – between the
concentration of gene transcripts and respective proteins
may result from differentiated stability of mRNAs and/or
proteins as well as from independent regulation of tran-
scription, posttranscriptional processes or translation and
functioning feedbacks, i.e. high protein concentration may
suppress mRNA synthesis. Moreover, steroids themselves
may alter the stability of mRNA [32]. It is also noteworthy
that the processes of transcription and translation are not
equally efficient.
The uterus is a target organ for ovarian steroid hor-
mones and undergoes marked changes during the estrous
cycle, including: tissue expansion (by 40-60%) and an
increase in uterine gland activity during luteal phase [33],
hyperemia [34] as well as increased capillary permeability
[33]. These changes require increased synthesis of AQPs.
In the present study, as documented by Western blot ana-
lysis, P4 and E2 appeared to be effective in controlling
AQP1 and AQP5 expression in pigs, suggesting their cru-
cial role in this regulation during the mid-luteal phase of
the estrous cycle and luteolysis.
Arachidonic acid is metabolized in the uterus to pros-
taglandins (PGE2 and PGF2alpha), which are involved in
many reproductive activities including luteolysis, maternal
recognition of pregnancy, endometrial gene expression
and conceptus development [35–37]. Prostaglandin syn-
thesis is thus dependent upon accessibility of AA [38] and
the activity of enzymes involved in its metabolism [39]. In
our studies, its potential effect on AQP1 and 5 expression
in uterine tissue of cyclic pigs was tested. The expression
of AQP1 and 5 mRNAs were similarly down-regulated by
AA during the mid-luteal phase (after 3- and 24-h expos-
ition). Nevertheless, the expression of both AQPs at the
protein level was stimulated only during luteolysis in
response to shorter exposition to AA. This well corre-
sponds with physiological situation, since PGF2alpha is
released by endometrium (epithelial and stromal cells) [40]
in a pulsatile manner to cause corpus luteum regression
[41]. Thus, our data indirectly indicate that prostaglandins
may exert regulatory effects on AQP1 and 5 in uterine
tissue. Studies performed by Zelenina et al. [42] have
confirmed the interaction of PGE2 with AVP in the
regulation of AQP2 in the rat renal medulla. Nevertheless,
the potential involvement of prostaglandins in the regu-
lation of AQPs in the pig uterus requires explanation in
further experiments.
Oxytocin is one of the key hormones implicated in
controlling the uterine functions. Among others, it affects
phosphoinositide hydrolysis [43], expression of COX-2 in
uterine tissue [37] and regulates PGF2alpha secretion [43].
The main reason for investigating the effect of oxytocin
on AQP1 and AQP5 expression was that pig endomet-
rium secretes oxytocin [44] and possesses its receptors
[45]. In the uterus, the concentration of OT receptor in
the endometrium changes during the estrous cycle. It has
been reported that in the middle luteal phase of the cycle,
the density of OT receptor increases in the endometrium
and myometrium [46]. In the present experiments, OT
decreased AQP1 and AQP5 mRNA expression (after 3-
and 24-h incubations), without visible changes in protein
content. In the pig during luteolytic period, oxytocin is
responsible for pulsatile secretion of PGF2alpha and con-
tractions of myometrium [47]. It might be hypothesized
that under physiological conditions, inhibitory action of
OT on AQP1 and 5 uterine expression at a transcriptional
level is connected with remodeling of endometrial tissues
taking place at the end of the luteal phase [33]. Very
recently, Ducza et al. [48] demonstrated increased AQP2
mRNA, but reduced AQP5mRNA expression by OT in the
rat uterus on Day 18 of pregnancy. Since the role of oxyto-
cin, similar to PGs, in the regulation of AQPs expression
and uterine fluid balance, so far is not sufficiently defined,
therefore further work is needed to better delineate it.
Previous studies confirmed that intracellular signaling
pathway consisting of adenylate cyclase (AC) and cAMP
(See figure on previous page.)
Figure 5 Immunohistochemical localization of AQP1 and AQP5 in uterine tissue explants. Immunoperoxidase staining of AQP1 in
paraffin-embedded sections of the uterine explants from pigs. Anti-AQP1 antibody labels endothelial cells of the uterine explants (arrows). Both
apical and basal plasma membranes exhibited stable AQP1 labeling (A/ an example of the staining for the control and B/ from the E2-treated
uterine explants for 24-h on Days 14–16 of the cycle). Immunoperoxidase labeling of AQP1 in the pig kidney cortex (Y/ positive control). The
labeling is seen in both of the apical and basolateral plasma membrane in proximal tubule cells. AQP5 antibody stains epithelial cells of the uterine
explants (arrows). The labeling is seen only in the apical plasma membranes of the epithelial cells (C/ an example of the staining for the control on
Days 14–16 of the cycle). Continuously, 3- and 24-h treatments on Days 10–12 and 14–16 of the estrous cycle of the tissue explants with P4 (D-E and
F-G), E2 (H-I and J-K), FSK (L-M and N-O) and cAMP (P-Q and R-S), respectively, prominent AQP5 labeling is seen in both the apical and basolateral
plasma membranes of the epithelial cells. A similar pattern of AQP5 labeling is also seen after 3-h treatment with AA on Days 14–16 of the estrous
cycle (T). AQP5 antibody also stains smooth muscle cells (U/ an example of the staining for the control andW/ from the E2-treated uterine explants
for 24-h on Days 14–16 of the cycle). The anti-AQP5 labels apical membrane of type I pulmonary epithelial cells of the pig (Z/ positive control). No
staining was observed with using non-immune immunoglobulins (negative controls: X1 – AQP1 and X5 – AQP5 controls). L – lumen. Bar = 50 μm.
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may be involved in the regulation of AQP expression
[21–23]. In the present study, the effects of cAMP and
forskolin (AC activator) on AQP1 and 5 in the uterine
tissue were tested. The treatment with cAMP did not
cause striking changes in expression of studied AQP
mRNAs in the uterine tissue; only increased AQP1
expression on Days 14–16 (after 24 h) and decreased
AQP5 on Days 10–12 (after 3 h) and Days 14–16 (after
24 h) of the estrous cycle. In a different experimental
model, Wang et al. [22] failed to see any changes in the
expression of AQP1, 8 or 9 genes in human amnion-
derived WISH cells after in vitro treatment with cAMP
analog. In our studies, the opposite reaction of AQP5
mRNA versus protein in response to cAMP is compli-
cated. This discrepancy may result from the regulatory
mechanism functioning at the transcription and transla-
tion levels, as discussed earlier and requires an explan-
ation in further studies. The effects of forskolin on
AQP1 and 5 mRNAs were very similar to those observed
in response to cAMP; i.e. stimulation of AQP1 and
mostly inhibition of AQP5 (except stimulation on Day
14–16 after 24 h incubation). At the protein level, the
expression of AQP1 and AQP5 was up-regulated by
forskolin, as in response to cAMP. Studies performed
with the use of different cells/tissues [9, 22, 23, 49] or
cell lines [21, 23, 24] also confirmed the stimulatory
effect of cAMP and/or forskolin on the expression of
AQP1 [24], AQP5 [23] and AQP3, 8 and 9 [9, 21, 23,
49]. Furthermore, AQP1 appeared to be up-regulated by
arginine vasopressin and cAMP analogue in trophoblast
cells [24]. On the basis of our study, it might be con-
cluded that the AC/cAMP pathway participates in the
regulation of AQP5 expression in the uterine tissue.
However, the engagement of the AC/cAMP pathway,
particularly in the regulation of AQP1 expression in this
tissue during the estrous cycle remains to be elucidated.
The changes in cellular localization of AQP1 and AQP5
in response to the studied factors, visualized by immuno-
histochemistry, are particularly interesting (Figure 5).
In the uterine tissue, localization of AQP1 was predom-
inantly associated with apical and basal membranes of
endothelial cells, but AQP5 with apical membranes of
epithelial cells. It is noteworthy that steroid hormones
(P4 and E2), cAMP and forskolin caused an emergence
of AQP5 in basolateral membrane of the epithelial cells
during both studied periods. It might be thus hypothe-
sized, that these changes are connected with potentially
bidirectional transcellular water movement through
uterine epithelial cells. Garcia et al. [50] indicated that
cAMP may induce insertion of AQP8 within intracellular
vesicular structures and translocation to plasma mem-
branes in the rat hepatocytes. Further experiments are
necessary to further explain the role of AQPs in uterine
water balance in cyclic gilts.
Conclusions
The present studies delineated the specific AQP1 and
AQP5 expression patterns in response to P4, E2, AA,
FSK and cAMP and indirectly provided novel evidence
for the role of AQP1 and AQP5 in maintaining local
fluid balance within the uterus during mid-luteal phase
of the estrous cycle and luteolysis in pigs. They revealed
that: (1) steroid hormones (P4 and E2), oxytocin and pre-
sumably AA metabolites (prostaglandins) exhibit poten-
tial for regulation of AQP1 and 5 expression in porcine
uterine tissue during the luteal phase; (2) AQPs responses
to the studied factors depended on the stage of luteal
phase and duration of their action; (3) P4, E2, AA, forsko-
lin and cAMP cause translocation of AQP5 from apical to
the basolateral plasma membrane of the epithelial cells,
which might affect the transcellular water movement
(through epithelial cells) between uterine lumen and blood
vessels; (4) the AC/cAMP pathway is involved in the intra-
cellular signals transduction connected with the regulation
of AQPs expression in the pig uterus.
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